CX Institutional’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.54M | Buy |
16,123
+5,967
| +59% | +$2.42M | 0.23% | 101 |
|
|
2025
Q1 | $5.05M | Buy |
10,156
+196
| +2% | +$97.5K | 0.19% | 122 |
|
|
2024
Q4 | $5.18M | Buy |
9,960
+2,062
| +26% | +$1.07M | 0.21% | 122 |
|
|
2024
Q3 | $4.89M | Buy |
7,898
+6,691
| +554% | +$4.14M | 0.22% | 127 |
|
|
2024
Q2 | $667K | Buy |
1,207
+13
| +1% | +$7.19K | 0.03% | 336 |
|
|
2024
Q1 | $694K | Buy |
1,194
+17
| +1% | +$9.88K | 0.03% | 327 |
|
|
2023
Q4 | $625K | Buy |
1,177
+222
| +23% | +$118K | 0.03% | 308 |
|
|
2023
Q3 | $483K | Sell |
955
-327
| -26% | -$166K | 0.03% | 330 |
|
|
2023
Q2 | $669K | Buy |
1,282
+85
| +7% | +$44.3K | 0.03% | 323 |
|
|
2023
Q1 | $685K | Buy |
1,197
+140
| +13% | +$80.1K | 0.04% | 323 |
|
|
2022
Q4 | $582K | Buy |
1,057
+441
| +72% | +$243K | 0.04% | 350 |
|
|
2022
Q3 | $312K | Buy |
616
+14
| +2% | +$7.09K | 0.02% | 387 |
|
|
2022
Q2 | $327K | Sell |
602
-25
| -4% | -$13.6K | 0.02% | 376 |
|
|
2022
Q1 | $370K | Buy |
627
+47
| +8% | +$27.7K | 0.03% | 290 |
|
|
2021
Q4 | $387K | Buy |
580
+31
| +6% | +$20.7K | 0.03% | 263 |
|
|
2021
Q3 | $314K | Buy |
549
+17
| +3% | +$9.72K | 0.03% | 312 |
|
|
2021
Q2 | $268K | Buy |
532
+15
| +3% | +$7.56K | 0.02% | 310 |
|
|
2021
Q1 | $236K | Buy |
517
+9
| +2% | +$4.11K | 0.02% | 288 |
|
|
2020
Q4 | $237K | Buy |
508
+26
| +5% | +$12.1K | 0.02% | 281 |
|
|
2020
Q3 | $213K | Buy |
482
+178
| +59% | +$78.7K | 0.02% | 258 |
|
|
2020
Q2 | $110K | Buy |
304
+22
| +8% | +$7.96K | 0.01% | 280 |
|
|
2020
Q1 | $80K | Buy |
282
+114
| +68% | +$32.3K | 0.01% | 287 |
|
|
2019
Q4 | $55K | Hold |
168
| – | – | 0.01% | 275 |
|
|
2019
Q3 | $49K | Buy |
168
+46
| +38% | +$13.4K | 0.01% | 299 |
|
|
2019
Q2 | $36K | Sell |
122
-9
| -7% | -$2.66K | 0.01% | 342 |
|
|
2019
Q1 | $36K | Buy |
+131
| New | +$36K | 0.01% | 348 |
|